Nurosym announces that replacement earpieces for its CE-marked vagus nerve stimulation device are in stock with UK-wide shipping - giving existing users a simple means of ordering spare or replacement parts.

-- With a recent stock update, Parasym confirms that replacement earpieces for its Nurosym device are available to purchase in the UK - offering users a straightforward way to source spare or replacement parts for their device. The news will be of interest to those who’ve been waiting to order a new earpiece in the event of loss or standard wear and tear, helping to keep their Nurosym running as intended.
For more information, visit: https://nurosym.com/products/earpiece
Nurosym’s team describes the earpieces as components with a vital job despite their small size: they’re designed to clip onto the tragus, the part of the outer ear just in front of the ear canal, and deliver the electrical pulses used in Nurosym's AVNT™ vagus nerve stimulation technology. Dr Elisabetta Burchi, Parasym’s Head of Research, explains that the vagus nerve is a prime target for stimulation - chiefly due to its physiological location.
“The vagus nerve sits at the intersection of autonomic and immune regulation - which is why it is a plausible target for supporting recovery.”
Recovery in this way relies on enhanced parasympathetic activity, says Dr Burchi - and, crucially, Nurosym’s earpiece is highlighted as the all-important part that makes contact with the body to carry out the requisite stimulation.
As such, while the earpiece itself is built to be durable, it’s also described as a consumable part that wears with regular usage - and consistent performance depends on the electrode staying in good condition. When it wears down, comfort and function can also be affected - another reason why the company specifically recommends keeping a spare earpiece aside.
Notably, a 6-month warranty is provided for the earpiece electrode, during which time a replacement can be issued at no extra cost. Once that period has passed, replacements can be bought through the company’s expanding Accessories Store - which lists earpieces for both the left and right ears, compatible only with the Nurosym device.
About Nurosym
Nurosym is a CE-marked Class IIa medical device, noted as a fully wearable, non-invasive vagus nerve stimulation offering. With linked benefits ranging from improved mood and energy to reductions in stress levels and even heightened recovery rates, research behind the device has been conducted as part of collaborations with institutions such as University College London, Barts NHS Trust, and more.
Dr Burchi adds: “We have published more than 50 studies showcasing safety and efficacy in various conditions, making our device the safest and most studied CE-Marked non-invasive vagal neuromodulator.”
Interested parties can find further details at: https://nurosym.com/
Disclaimer: Research referenced in this article was conducted using Parasym’s neuromodulation technology under research conditions. Findings relate to specific study populations and should not be interpreted as medical claims or guaranteed individual outcomes. Nurosym is a CE-marked medical device in Europe.
Contact Info:
Name: PR Team
Email: Send Email
Organization: Nurosym by Parasym
Address: 18 Saint Cross Street 4th Floor, London, England EC1N 8UN, United Kingdom
Website: https://nurosym.com/
Source: PressCable
Release ID: 89205836
If you come across any problems, discrepancies, or concerns related to the content contained within this press release that necessitate action or if a press release requires takedown, we strongly encourage you to reach out without delay by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will be readily accessible round-the-clock to address your concerns within 8 hours and take appropriate actions to rectify identified issues or support with press release removals. Ensuring accurate and reliable information remains our unwavering commitment.